Testing effectiveness (Phase 2)Ended earlyNCT02605304
What this trial is testing
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Who this might be right for
HIV-1 InfectionHepatitis C
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 7